tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Balaji Prasad, 22 are a SELL (11.52%), 20 are a HOLD (10.47%), 149 are a BUY (78.01%).
Analyst Balaji Prasad, currently employed at BARCLAYS, carries an average stock price target met ratio of 49.41% that have a potential upside of 24.91% achieved within 247 days.
Balaji Prasad’s has documented 380 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PCRX, Pacira Pharmaceuticals at 12-Nov-2024.
Analyst best performing recommendations are on MNK (MALLINCKRODT PLC).
The best stock recommendation documented was for MNK (MALLINCKRODT PLC) at 4/2/2020. The price target of $3 was fulfilled within 7 days with a profit of $1.2 (66.67%) receiving and performance score of 95.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$11
$3.19 (40.85%)
$8.5
1 months 19 days ago
(01-Nov-2024)
11/23 (47.83%)
$1.22 (12.47%)
187
Hold
$3
$-4.81 (-61.59%)
$6
4 months 18 days ago
(02-Aug-2024)
10/13 (76.92%)
$-2.63 (-46.71%)
203
Hold
$8
$0.19 (2.43%)
$8
5 months 10 days ago
(10-Jul-2024)
8/9 (88.89%)
$0.68 (9.29%)
68
Buy
$16
$8.19 (104.87%)
1 years 3 months ago
(20-Sep-2023)
0/1 (0%)
$7.66 (91.85%)
Buy
$16
$8.19 (104.87%)
$9.5
1 years 3 months ago
(20-Sep-2023)
4/5 (80%)
$7.66 (91.85%)
143
Which stock is Balaji Prasad is most bullish on?
Which stock is Balaji Prasad is most reserved on?
What Year was the first public recommendation made by Balaji Prasad?
